Blood Testing Market

Blood Testing Market Summary

The global blood testing market is experiencing strong growth, driven by the rising prevalence of chronic and infectious diseases, growing aging population, and increasing adoption of personalized and preventive healthcare practices. Rapid technological innovations such as point-of-care testing, lab-on-a-chip platforms, and AI-enabled diagnostics are transforming how and where blood tests are performed, making testing faster, more accurate, and more accessible.

The Global Blood Testing Market Highlights

• Market Value (2024) US$ 104.4 Bn – Reflects the widespread use of diagnostic testing.
• Forecast Period 2025–2035 – Growth supported by preventive healthcare and technology adoption.
• Expected CAGR 8.2% – Strong annual expansion driven by chronic disease management and automation.
• Forecast Value (2034) US$ 249.7 Bn – Demonstrates increasing reliance on rapid, accurate diagnostics.

Expert Insights and Strategic Overview

The blood testing market is expanding rapidly as healthcare systems shift toward preventive and personalized medicine. The growing global burden of diabetes, cardiovascular disease, cancer, and infectious disorders is boosting demand for routine diagnostics and early detection.

At the same time, innovations in AI-powered analyzers, automated lab systems, and point-of-care (POC) devices are enhancing testing speed, reliability, and accessibility. Lab-on-a-chip and digital health platforms now enable on-demand diagnostics, connecting laboratories, clinics, and home-testing users.

Although challenges remain—such as regulatory complexity, high cost of advanced systems, and limited access in resource-poor settings—ongoing collaboration among manufacturers, healthcare providers, and research institutions is fostering innovation and global market expansion.

Market Introduction

Blood testing is one of the most fundamental diagnostic tools in healthcare, providing insights into a person’s health status, organ function, and disease progression. It is routinely used for monitoring chronic conditions, detecting infections, and evaluating treatment efficacy.

Blood tests also play a critical role in early diagnosis and prevention—supporting population-level screening programs, precision medicine initiatives, and real-time monitoring through wearable and home-based technologies.

Key Market Drivers

Rising Prevalence of Chronic Diseases to Boost Market Share

The growing number of patients suffering from chronic diseases such as diabetes, cardiovascular disorders, and cancer has heightened the need for regular diagnostic testing. Blood tests enable early detection and monitoring through biomarkers and disease indicators.

As per global data, chronic disease incidence continues to rise sharply, especially among aging populations. This has led to increased demand for point-of-care testing, lab-based assays, and routine screenings, all of which are accelerating blood testing market growth.

Rapid Technological Advancements Fueling Market Expansion

Emerging technologies—such as automated analyzers, lab-on-a-chip devices, liquid biopsy, AI integration, and next-generation sequencing (NGS)—are revolutionizing how blood tests are conducted.

These innovations have reduced test turnaround times from days to minutes, improved accuracy, and expanded accessibility across remote and underserved regions. Cloud-based data systems and telehealth integration further enable real-time result sharing and personalized treatment management.

Glucose Testing Segment Driving Global Market Growth

Among all test types, the glucose testing segment dominates due to the global rise in diabetes prevalence. Frequent blood glucose monitoring, both clinical and self-administered, remains essential for disease management.

Technological advances such as needle-free sampling, real-time glucose monitoring, and digital connectivity make these systems more user-friendly and aligned with patient convenience. Continuous innovation and supportive regulatory pathways will ensure this segment’s leadership through 2035.

Regional Outlook

North America holds the largest market share owing to robust healthcare infrastructure, high public awareness, and favorable reimbursement policies. The region’s concentration of leading diagnostic companies and rapid technology adoption support sustained growth.

Asia Pacific is projected to record the fastest CAGR through 2035, fueled by rising healthcare access, public health initiatives, and increasing rates of chronic and infectious diseases. Government investment in diagnostic infrastructure and local production capabilities are further stimulating regional expansion.

Competitive Landscape

Prominent companies in the global blood testing market are strengthening their portfolios with AI-driven platforms, home-testing innovations, and strategic collaborations.

Leading Market Players

• Abbott
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories
• BIOMÉRIEUX
• Quest Diagnostics
• Grifols, S.A.
• Sysmex Corporation
• Guardant Health
• GRAIL, Inc.
• Everlywell
• Freenome Holdings, Inc.
• Hologic, Inc.
• Trinity Biotech

These companies are investing in digital diagnostics, biomarker discovery, and automation technologies to improve test accuracy and broaden global market access.

Key Developments

• May 2025 Fujirebio received FDA clearance for LumipulseG pTau 217/β-Amyloid 1-42 Plasma Ratio, the first blood-based IVD test in the U.S. for assessing amyloid pathology linked to Alzheimer’s Disease.
• December 2024 BD (Becton, Dickinson and Company) and Babson Diagnostics expanded fingertip blood collection and testing technologies for large healthcare networks.
• July 2024 Guardant Health, Inc. received FDA approval for its Shield blood test for colorectal cancer screening in adults aged 45+, marking the first FDA-approved blood test for CRC screening with Medicare coverage eligibility.

Blood Testing Market Snapshot

Segmentation Overview

By Test Type

• Glucose Testing
• A1C Testing
• Direct LDL Testing
• Lipid Panel Testing
• Prostate Specific Antigen Testing
• COVID-19 Testing
• BUN Testing
• Vitamin D Testing
• TSH Testing
• Serum Nicotine/Cotinine Testing
• High Sensitivity CRP Testing
• Testosterone Testing
• ALT Testing
• Cortisol Testing
• Creatinine Testing
• AST Testing
• Other Blood Tests

By Method

• Manual Blood Testing
• Automated Blood Testing

By End User

• Hospitals
• Diagnostic Centers
• Research Laboratories
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa